{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:49:49Z","timestamp":1775645389199,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":1540,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1111\/ajt.14977","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T05:39:56Z","timestamp":1529991596000},"page":"2120-2134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Meeting report of the STAR\u2014Sensitization in Transplantation Assessment of Risk: Na\u00efve Abdominal Transplant Organ subgroup focus on kidney transplantation"],"prefix":"10.1016","volume":"18","author":[{"given":"Roslyn B.","family":"Mannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhat","family":"Askar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Newell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1111\/ajt.14977_bib1","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant."},{"issue":"17\u201318","key":"10.1111\/ajt.14977_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cca.2012.03.006","article-title":"T-cell immune monitoring by the ELISPOT assay for interferon gamma","volume":"413","author":"Augustine","year":"2012","journal-title":"Clin Chim Acta."},{"issue":"12","key":"10.1111\/ajt.14977_bib3","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1111\/ajt.13401","article-title":"Interferon gamma ELISPOT testing as a risk-stratifying biomarker for kidney transplant injury: results from the CTOT-01 multicenter study","volume":"15","author":"Hricik","year":"2015","journal-title":"Am J Transplant."},{"issue":"14","key":"10.1111\/ajt.14977_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med."},{"issue":"11","key":"10.1111\/ajt.14977_bib5","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1111\/ajt.12462","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.14977_bib6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1681\/ASN.2014080837","article-title":"Utility of HLA antibody testing in kidney transplantation","volume":"26","author":"Konvalinka","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"10.1111\/ajt.14977_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.kint.2016.10.040","article-title":"Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies","volume":"91","author":"Haas","year":"2017","journal-title":"Kidney Int."},{"issue":"8","key":"10.1111\/ajt.14977_bib8","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"9470","key":"10.1111\/ajt.14977_bib9","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies","volume":"365","author":"Opelz","year":"2005","journal-title":"The Lancet."},{"issue":"10","key":"10.1111\/ajt.14977_bib10","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.14977_bib11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/TP.0000000000000511","article-title":"Characteristics of circulating donor human leukocyte antigen-specific immunoglobulin G antibodies predictive of acute antibody-mediated rejection and kidney allograft failure","volume":"99","author":"Kannabhiran","year":"2015","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.14977_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.12533","article-title":"Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients","volume":"28","author":"Huber","year":"2015","journal-title":"Transpl Int."},{"issue":"5","key":"10.1111\/ajt.14977_bib13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0000000000000469","article-title":"Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients","volume":"99","author":"Lim","year":"2015","journal-title":"Transplantation."},{"key":"10.1111\/ajt.14977_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.trim.2016.03.002","article-title":"Comprehensive assessment of sensitizing events and anti-HLA antibody development in women awaiting kidney transplantation","volume":"36","author":"Picascia","year":"2016","journal-title":"Transpl Immunol."},{"issue":"12","key":"10.1111\/ajt.14977_bib15","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"10.1111\/ajt.14977_bib16","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/ajt.13848","article-title":"Clinical significance of pretransplant donor-specific antibodies in the setting of negative cell-based flow cytometry crossmatching in kidney transplant recipients","volume":"16","author":"Adebiyi","year":"2016","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.14977_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss","volume":"28","author":"Viglietti","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"13","key":"10.1111\/ajt.14977_bib18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1111\/ajt.14977_bib19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/TP.0b013e3182139da1","article-title":"Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes","volume":"91","author":"Cooper","year":"2011","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.14977_bib20","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/ajt.14161","article-title":"The value of protocol biopsies to identify patients with de novo donor specific antibody at high risk for allograft loss","volume":"17","author":"Schinstock","year":"2017","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.14977_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/ajt.12048","article-title":"Frequency and determinants of pregnancy-induced child-specific sensitization","volume":"13","author":"H\u00f6nger","year":"2013","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.14977_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/00007890-200103150-00021","article-title":"Increased costimulatory responses in African-American kidney allograft recipients","volume":"71","author":"Hutchings","year":"2001","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.14977_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1523-1755.2004.00871.x","article-title":"Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function","volume":"66","author":"Mange","year":"2004","journal-title":"Kidney Int."},{"issue":"5","key":"10.1111\/ajt.14977_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1432-2277.2010.01205.x","article-title":"Racial and ethnic disparities in kidney transplantation","volume":"24","author":"Malek","year":"2011","journal-title":"Transpl Int."},{"issue":"11","key":"10.1111\/ajt.14977_bib25","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/ndt\/gft362","article-title":"Sensitization from transfusion in patients awaiting primary kidney transplant","volume":"28","author":"Yabu","year":"2013","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"10.1111\/ajt.14977_bib26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/ctr.12632","article-title":"Older kidney transplant patients experience less antibody-mediated rejection: a retrospective study of patients with mild to moderate sensitization","volume":"29","author":"Scalea","year":"2015","journal-title":"Clin Transplant."},{"issue":"4","key":"10.1111\/ajt.14977_bib27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gfv391","article-title":"Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation","volume":"31","author":"Perasaari","year":"2016","journal-title":"Nephrol Dial Transplant."},{"key":"10.1111\/ajt.14977_bib28","first-page":"231","article-title":"Early de novo donor specific antibody involvement in delayed graft function after kidney transplantation: a report of 2 cases","author":"Zhu","year":"2014","journal-title":"Clin Transpl."},{"issue":"5","key":"10.1111\/ajt.14977_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-6143.2009.02577.x","article-title":"Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss","volume":"9","author":"Everly","year":"2009","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.14977_bib30","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.14977_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.TP.0000438215.16737.68","article-title":"Organ donation and transplantation in the UK\u2014the last decade: a report from the UK national transplant registry","volume":"97","author":"Johnson","year":"2014","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.14977_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/TP.0b013e318298f9db","article-title":"Relative importance of HLA mismatch and donor age to graft survival in young kidney transplant recipients","volume":"96","author":"Foster","year":"2013","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.14977_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.ackd.2016.09.007","article-title":"Immunosuppression minimization and avoidance protocols: when less is not more","volume":"23","author":"Prashar","year":"2016","journal-title":"Adv Chronic Kidney Dis."},{"issue":"9955","key":"10.1111\/ajt.14977_bib34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(14)61095-3","article-title":"Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial","volume":"384","author":"Haynes","year":"2014","journal-title":"Lancet."},{"issue":"8","key":"10.1111\/ajt.14977_bib35","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2009.02710.x","article-title":"BAFF is increased in renal transplant patients following treatment with alemtuzumab","volume":"9","author":"Bloom","year":"2009","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.14977_bib36","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1203261","article-title":"In kidney transplant patients, alemtuzumab but not basiliximab\/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development","volume":"191","author":"Todeschini","year":"2013","journal-title":"J Immunol."},{"issue":"11","key":"10.1111\/ajt.14977_bib37","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1111\/ajt.13830","article-title":"Long-term outcomes in belatacept- versus cyclosporine-treated recipients of extended criteria donor kidneys: final results from BENEFIT-EXT, a phase III randomized study","volume":"16","author":"Durrbach","year":"2016","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.14977_bib38","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/ajt.13946","article-title":"Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients","volume":"16","author":"Dugast","year":"2016","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.14977_bib39","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1681\/ASN.2014121234","article-title":"Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients","volume":"26","author":"Hricik","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"10.1111\/ajt.14977_bib40","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/ajt.13710","article-title":"Calcineurin inhibitor minimization, conversion, withdrawal, and avoidance strategies in renal transplantation: a systematic review and meta-analysis","volume":"16","author":"Sawinski","year":"2016","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.14977_bib41","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/TP.0000000000000448","article-title":"De novo donor-specific human leukocyte antigen antibodies in nonsensitized kidney transplant recipients after T cell-mediated rejection","volume":"99","author":"Chemouny","year":"2015","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.14977_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31823bb647","article-title":"Early subclinical rejection as a risk factor for late chronic humoral rejection","volume":"93","author":"Moreso","year":"2012","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.14977_bib43","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2014010119","article-title":"Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies","volume":"26","author":"Sawinski","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"10.1111\/ajt.14977_bib44","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/tid.12467","article-title":"Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction","volume":"17","author":"Dieplinger","year":"2015","journal-title":"Transpl Infect Dis."},{"issue":"11","key":"10.1111\/ajt.14977_bib45","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development","volume":"28","author":"Wiebe","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"10.1111\/ajt.14977_bib46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.14977_bib47","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"10.1111\/ajt.14977_bib48","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.14977_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.14977_bib50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-Complement-binding de novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.14977_bib51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/tri.12887","article-title":"De Novo donorspecific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability","volume":"30","author":"Kauke","year":"2017","journal-title":"Transpl Int."},{"key":"10.1111\/ajt.14977_bib52","doi-asserted-by":"crossref","unstructured":"Sharma A, Lewis JR, Lim WH, et al. Renal transplant outcomes and de novo donor-specific anti-human leukocyte antigen antibodies: a systematic review [published online ahead of print 2018]. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfy077","DOI":"10.1093\/ndt\/gfy077"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14977","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352209685X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352209685X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14977\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:22:00Z","timestamp":1761628920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352209685X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S160061352209685X"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14977","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meeting report of the STAR\u2014Sensitization in Transplantation Assessment of Risk: Na\u00efve Abdominal Transplant Organ subgroup focus on kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}